1. Home
  2. IPSC vs ZKH Comparison

IPSC vs ZKH Comparison

Compare IPSC & ZKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.31

Market Cap

413.0M

Sector

Health Care

ML Signal

HOLD

ZKH

ZKH Group Limited

HOLD

Current Price

$2.98

Market Cap

484.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPSC
ZKH
Founded
2019
1998
Country
United States
China
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
413.0M
484.8M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
IPSC
ZKH
Price
$2.31
$2.98
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$4.25
N/A
AVG Volume (30 Days)
739.4K
346.2K
Earning Date
05-11-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
91.30
N/A
EPS
N/A
N/A
Revenue
$109,164,000.00
N/A
Revenue This Year
N/A
$9.02
Revenue Next Year
N/A
$10.41
P/E Ratio
N/A
N/A
Revenue Growth
1556.76
N/A
52 Week Low
$0.44
$2.20
52 Week High
$2.97
$3.90

Technical Indicators

Market Signals
Indicator
IPSC
ZKH
Relative Strength Index (RSI) 50.25 43.03
Support Level $2.15 $2.78
Resistance Level $2.67 $3.09
Average True Range (ATR) 0.12 0.11
MACD 0.00 0.00
Stochastic Oscillator 62.00 19.05

Price Performance

Historical Comparison
IPSC
ZKH

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

About ZKH ZKH Group Limited

ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.

Share on Social Networks: